Capital World Investors Crispr Therapeutics Ag Transaction History

Capital World Investors

  • $633 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$53.19 - $79.24 $22.4 Million - $33.4 Million
-421,486 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $29.5 Million - $46.9 Million
421,486 New
421,486 $31.9 Million
Q3 2018

Nov 14, 2018
SELL
$44.35 - $65.71 $6.12 Million - $9.07 Million
-138,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$23.52 - $58.17 $3.25 Million - $8.03 Million
138,000 New
138,000 $6.31 Million

Others Institutions Holding CRSP

# of Institutions
487
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.42B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email